Skip header and navigation

Refine By

821 records – page 1 of 83.

The 6th Klaas Breur memorial lecture, 1987. The Chernobyl accident--impact Western Europe.

https://arctichealth.org/en/permalink/ahliterature25858
Source
Radiother Oncol. 1988 May;12(1):1-13
Publication Type
Article
Date
May-1988

99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis.

https://arctichealth.org/en/permalink/ahliterature144028
Source
Clin Exp Immunol. 2010 Apr;160(1):106-12
Publication Type
Article
Date
Apr-2010
Author
L. Chatenoud
S. You
H. Okada
C. Kuhn
B. Michaud
J-F Bach
Author Affiliation
Université Paris Descarte, Paris, France. lucienne.chatenoud@inserm.fr
Source
Clin Exp Immunol. 2010 Apr;160(1):106-12
Date
Apr-2010
Language
English
Publication Type
Article
Keywords
Adolescent
Animals
Autoantigens - immunology
Bacteria - immunology
Canada - epidemiology
Child
Diabetes Mellitus, Type 1 - immunology - therapy
Europe - epidemiology
Humans
Hygiene
Hypersensitivity - immunology
Immunosuppression - methods
Immunotherapy - methods
Infection - immunology - microbiology
Mice
Pancreatitis - immunology - microbiology
Toll-Like Receptors - agonists
Young Adult
Abstract
Insulin-dependent (type 1) diabetes is a prototypic organ-specific autoimmune disease resulting from the selective destruction of insulin-secreting beta cells within pancreatic islets of Langerhans by an immune-mediated inflammation involving autoreactive CD4(+) and CD8(+) T lymphocytes which infiltrate pancreatic islets. Current treatment is substitutive, i.e. chronic use of exogenous insulin which, in spite of significant advances, is still associated with major constraints (multiple daily injections, risks of hypoglycaemia) and lack of effectiveness over the long term in preventing severe degenerative complications. Finding a cure for autoimmune diabetes by establishing effective immune-based therapies is a real medical health challenge, as the disease incidence increases steadily in industrialized countries. As the disease affects mainly children and young adults, any candidate immune therapy must therefore be safe and avoid a sustained depression of immune responses with the attendant problems of recurrent infection and drug toxicity. Thus, inducing or restoring immune tolerance to target autoantigens, controlling the pathogenic response while preserving the host reactivity to exogenous/unrelated antigens, appears to be the ideal approach. Our objective is to review the major progress accomplished over the last 20 years towards that aim. In addition, we would like to present another interesting possibility to access new preventive strategies based on the 'hygiene hypothesis', which proposes a causal link between the increasing incidence of autoimmune diseases, including diabetes, and the decrease of the infectious burden. The underlying rationale is to identify microbial-derived compounds mediating the protective activity of infections which could be developed therapeutically.
Notes
Cites: J Immunol. 2000 Jun 1;164(11):5683-810820244
Cites: Clin Exp Immunol. 2010 Apr;160(1):1-920415844
Cites: Lancet. 2000 Aug 12;356(9229):545-910950231
Cites: Diabetologia. 2000 Aug;43(8):1000-410990077
Cites: J Immunol. 2000 Dec 1;165(11):6148-5511086048
Cites: Annu Rev Immunol. 2001;19:131-6111244033
Cites: J Immunol. 2001 Jul 15;167(2):1081-911441119
Cites: Lancet. 2001 Nov 24;358(9295):1749-5311734230
Cites: Nature. 2002 Apr 11;416(6881):603-711948342
Cites: Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5539-4411943868
Cites: N Engl J Med. 2002 May 30;346(22):1685-9112037147
Cites: N Engl J Med. 2002 May 30;346(22):1740-212037155
Cites: N Engl J Med. 2002 Sep 19;347(12):911-2012239261
Cites: Vaccine. 2003 Feb 14;21(9-10):836-4212547591
Cites: Int Immunopharmacol. 2003 Mar;3(3):417-2512639819
Cites: Science. 1984 Mar 30;223(4643):1362-76367043
Cites: Lancet. 1986 Jul 19;2(8499):119-242873396
Cites: Diabetes. 1986 Aug;35(8):855-603525284
Cites: J Exp Med. 1989 May 1;169(5):1669-802523954
Cites: BMJ. 1989 Nov 18;299(6710):1259-602513902
Cites: J Autoimmun. 1989 Dec;2(6):759-762533502
Cites: Chem Pharm Bull (Tokyo). 1992 Apr;40(4):1004-61525928
Cites: Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):123-78278351
Cites: Endocr Rev. 1994 Aug;15(4):516-427988484
Cites: Diabetes Metab. 1996 Oct;22(5):341-88896996
Cites: J Exp Med. 1996 Nov 1;184(5):2049-538920894
Cites: J Immunol. 1997 Mar 15;158(6):2947-549058834
Cites: Immunology. 1962 May;5:378-8813887798
Cites: Nat Med. 2005 Feb;11(2):138-4515654326
Cites: N Engl J Med. 2005 Jun 23;352(25):2598-60815972866
Cites: J Exp Med. 2005 Oct 17;202(8):1131-916230478
Cites: J Exp Med. 2005 Nov 7;202(9):1171-716260486
Cites: Diabetes. 2006 Jan;55(1):179-8516380491
Cites: J Neuroimmunol. 2006 Mar;172(1-2):94-10316360885
Cites: Immunol Rev. 2006 Aug;212:185-20216903915
Cites: J Med Chem. 2006 Oct 5;49(20):6000-1417004714
Cites: Immunobiology. 2006;211(10):767-7717113914
Cites: Nat Rev Immunol. 2007 May;7(5):353-6417457343
Cites: Pediatr Diabetes. 2007 Oct;8 Suppl 6:6-1417727380
Cites: J Clin Invest. 2007 Dec;117(12):3857-6718060033
Cites: N Engl J Med. 2008 Feb 14;358(7):676-8818272891
Cites: J Immunol. 2008 Mar 1;180(5):2863-7518292508
Cites: Lancet. 2008 May 24;371(9626):1777-8218502302
Cites: N Engl J Med. 2008 Oct 30;359(18):1909-2018843118
Cites: Lancet. 2008 Nov 15;372(9651):1746-5518814906
Cites: Nat Rev Endocrinol. 2009 Apr;5(4):219-2619352320
Cites: Lancet. 2009 Jun 13;373(9680):2027-3319481249
Cites: Diabetes Care. 2009 Nov;32(11):2036-4019690081
Cites: N Engl J Med. 2009 Nov 26;361(22):2143-5219940299
Cites: Eur J Biochem. 2000 Jun;267(11):3370-710824125
PubMed ID
20415859 View in PubMed
Less detail

The 1988 and 2002 phocine distemper virus epidemics in European harbour seals.

https://arctichealth.org/en/permalink/ahliterature6586
Source
Dis Aquat Organ. 2006 Jan 30;68(2):115-30
Publication Type
Article
Date
Jan-30-2006
Author
Tero Härkönen
Rune Dietz
Peter Reijnders
Jonas Teilmann
Karin Harding
Ailsa Hall
Sophie Brasseur
Ursula Siebert
Simon J Goodman
Paul D Jepson
Thomas Dau Rasmussen
Paul Thompson
Author Affiliation
Swedish Museum of Natural History, Box 50007, 10405 Stockholm, Sweden. tero.harkonen@swipnet.se
Source
Dis Aquat Organ. 2006 Jan 30;68(2):115-30
Date
Jan-30-2006
Language
English
Publication Type
Article
Keywords
Age Factors
Animals
Carnivora
Comparative Study
Disease Outbreaks - veterinary
Disease Reservoirs - veterinary
Disease Vectors
Distemper - epidemiology - mortality - pathology
Distemper Virus, Phocine
Environmental Exposure - adverse effects
Europe - epidemiology
Female
Male
Morbillivirus - classification - pathogenicity
Phoca - virology
Research Support, Non-U.S. Gov't
Sex Factors
Time Factors
Abstract
We present new and revised data for the phocine distemper virus (PDV) epidemics that resulted in the deaths of more than 23 000 harbour seals Phoca vitulina in 1988 and 30,000 in 2002. On both occasions the epidemics started at the Danish island of Anholt in central Kattegat, and subsequently spread to adjacent colonies in a stepwise fashion. However, this pattern was not maintained throughout the epidemics and new centres of infection appeared far from infected populations on some occasions: in 1988 early positive cases were observed in the Irish Sea, and in 2002 the epidemic appeared in the Dutch Wadden Sea, 6 wk after the initiation of the outbreak at Anholt Island. Since the harbour seal is a rather sedentary species, such 'jumps' in the spread among colonies suggest that another vector species could have been involved. We discussed the role of sympatric species as disease vectors, and suggested that grey seal populations could act as reservoirs for PDV if infection rates in sympatric species are lower than in harbour seals. Alternatively, grey seals could act as subclinical infected carriers of the virus between Arctic and North Sea seal populations. Mixed colonies of grey and harbour seal colonies are found at all locations where the jumps occurred. It seems likely that grey seals, which show long-distance movements, contributed to the spread among regions. The harbour seal populations along the Norwegian coast and in the Baltic escaped both epidemics, which could be due either to genetic differences among harbour seal populations or to immunity. Catastrophic events such as repeated epidemics should be accounted for in future models and management strategies of wildlife populations.
PubMed ID
16532603 View in PubMed
Less detail

The ABCA4 2588G>C Stargardt mutation: single origin and increasing frequency from South-West to North-East Europe.

https://arctichealth.org/en/permalink/ahliterature50771
Source
Eur J Hum Genet. 2002 Mar;10(3):197-203
Publication Type
Article
Date
Mar-2002
Author
Alessandra Maugeri
Kris Flothmann
Nadine Hemmrich
Sofie Ingvast
Paula Jorge
Eva Paloma
Reshma Patel
Jean-Michel Rozet
Jaana Tammur
Francesco Testa
Susana Balcells
Alan C Bird
Han G Brunner
Carel B Hoyng
Andres Metspalu
Francesca Simonelli
Rando Allikmets
Shomi S Bhattacharya
Michele D'Urso
Roser Gonzàlez-Duarte
Josseline Kaplan
Gerard J te Meerman
Rosário Santos
Marianne Schwartz
Guy Van Camp
Claes Wadelius
Bernhard H F Weber
Frans P M Cremers
Author Affiliation
Department of Human Genetics, University Medical Center Nijmegen, Nijmegen, The Netherlands. a.maugeri@antrg.azn.nl
Source
Eur J Hum Genet. 2002 Mar;10(3):197-203
Date
Mar-2002
Language
English
Publication Type
Article
Keywords
ATP-Binding Cassette Transporters - genetics
Alleles
Base Sequence
Europe
Gene Frequency
Heterozygote
Humans
Molecular Sequence Data
Mutation
Point Mutation
Research Support, Non-U.S. Gov't
United States
Abstract
Inherited retinal dystrophies represent the most important cause of vision impairment in adolescence, affecting approximately 1 out of 3000 individuals. Mutations of the photoreceptor-specific gene ABCA4 (ABCR) are a common cause of retinal dystrophy. A number of mutations have been repeatedly reported for this gene, notably the 2588G>C mutation which is frequent in both patients and controls. Here we ascertained the frequency of the 2588G>C mutation in a total of 2343 unrelated random control individuals from 11 European countries and 241 control individuals from the US, as well as in 614 patients with STGD both from Europe and the US. We found an overall carrier frequency of 1 out of 54 in Europe, compared with 1 out of 121 in the US, confirming that the 2588G>C ABCA4 mutation is one of the most frequent autosomal recessive mutations in the European population. Carrier frequencies show an increasing gradient in Europe from South-West to North-East. The lowest carrier frequency, 0 out of 199 (0%), was found in Portugal; the highest, 11 out of 197 (5.5%), was found in Sweden. Haplotype analysis in 16 families segregating the 2588G>C mutation showed four intragenic polymorphisms invariably present in all 16 disease chromosomes and sharing of the same allele for several markers flanking the ABCA4 locus in most of the disease chromosomes. These results indicate a single origin of the 2588G>C mutation which, to our best estimate, occurred between 2400 and 3000 years ago.
PubMed ID
11973624 View in PubMed
Less detail

Absence of indigenous specific West Nile virus antibodies in Tyrolean blood donors.

https://arctichealth.org/en/permalink/ahliterature134646
Source
Eur J Clin Microbiol Infect Dis. 2012 Jan;31(1):77-81
Publication Type
Article
Date
Jan-2012
Author
S T Sonnleitner
J. Simeoni
E. Schmutzhard
M. Niedrig
F. Ploner
H. Schennach
M P Dierich
G. Walder
Author Affiliation
Hygiene and Medical Microbiology, Medical University Innsbruck, Fritz Pregl Straße 1-3/III, Innsbruck, Austria. sissyson@gmx.at
Source
Eur J Clin Microbiol Infect Dis. 2012 Jan;31(1):77-81
Date
Jan-2012
Language
English
Publication Type
Article
Keywords
Adult
Antibodies, Viral - blood
Blood Donors
Child, Preschool
Encephalitis Viruses, Tick-Borne - immunology
Enzyme-Linked Immunosorbent Assay
Europe
False Positive Reactions
Female
Humans
Italy
Male
Middle Aged
Neutralization Tests
West Nile Fever - diagnosis - epidemiology - virology
West Nile virus - immunology
Abstract
In the last several years, West Nile virus (WNV) was proven to be present especially in the neighboring countries of Austria, such as Italy, Hungary, and the Czech Republic, as well as in eastern parts of Austria, where it was detected in migratory and domestic birds. In summer 2010, infections with WNV were reported from Romania and northern Greece with about 150 diseased and increasingly fatal cases. We tested the sera of 1,607 blood donors from North Tyrol (Austria) and South Tyrol (Italy) for antibodies against WNV by using IgG enzyme-linked immunosorbent assay (ELISA). Initial results of the ELISA tests showed seroprevalence rates of 46.2% in North Tyrol and 0.5% in South Tyrol, which turned out to be false-positive cross-reactions with antibodies against tick-borne encephalitis virus (TBEV) by adjacent neutralization assays. These results indicate that seropositivity against WNV requires confirmation by neutralization assays, as cross-reactivity with TBEV is frequent and because, currently, WNV is not endemic in the study area.
PubMed ID
21556676 View in PubMed
Less detail

Absence of the genetic variant Val79Met in human chorionic gonadotropin-beta gene 5 in five European populations.

https://arctichealth.org/en/permalink/ahliterature63350
Source
Mol Hum Reprod. 2004 Oct;10(10):763-6
Publication Type
Article
Date
Oct-2004
Author
Min Jiang
Marja-Liisa Savontaus
Henrik Simonsen
Catherine Williamson
Roman Müllenbach
Jörg Gromoll
Nicole Terwort
Maria Alevizaki
Ilpo Huhtaniemi
Author Affiliation
Department of Physiology, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland. min.jiang@utu.fi
Source
Mol Hum Reprod. 2004 Oct;10(10):763-6
Date
Oct-2004
Language
English
Publication Type
Article
Keywords
Chorionic Gonadotropin, beta Subunit, Human - genetics
Ethnic Groups
Europe
Female
Humans
Methionine - genetics
Polymorphism, Genetic
Pregnancy
Protein Isoforms - genetics
Random Allocation
Reproducibility of Results
Research Support, Non-U.S. Gov't
Sequence Analysis, DNA
Valine - genetics
Abstract
Chorionic gonadotropin (CG) is an essential signal in establishment and maintenance of pregnancy in humans and higher primates. A G-to-A transition in exon 3 of human CGbeta gene 5, changing the naturally occurring valine residue to methionine in codon 79 (Val(79)Met) has been reported at carrier frequency 4.2% in a random population from the Midwest of the United States. The biological activity of the variant hCG was similar to that of wild-type (WT) hCG. However, the Val(79)Met beta-subunit displayed impaired ability to assemble with alpha-subunit, and the amount of hCG alpha/beta heterodimers formed and secreted by transfected cells was seriously impaired in the previous study. Because of these functional implications we found it important to study the occurrence of the Val(79)Met hCGbeta variant in other populations. By using a PCR-RFLP method, a search for the Val(79)Met hCGbeta variant was carried out on a total of 580 DNA samples from five European populations (Finland, Denmark, Greece, Germany and the UK). The results demonstrated an absence of the polymorphism in these populations. Hence, the naturally occurring variant (Val(79)Met) of the hCGbeta gene 5, found previously at high frequency in the US, is clearly less common, or absent, in the European populations studied.
PubMed ID
15299093 View in PubMed
Less detail

Abstracts. Seventh annual meeting. The European Society for Paediatric Haematology and Immunology. Oslo, Norway, June 11-13, 1979.

https://arctichealth.org/en/permalink/ahliterature41315
Source
Pediatr Res. 1979 Aug;13(8):948-57
Publication Type
Conference/Meeting Material
Date
Aug-1979

The acceptability of isoflavones as a treatment of menopausal symptoms: a European survey among postmenopausal women.

https://arctichealth.org/en/permalink/ahliterature70456
Source
Climacteric. 2005 Sep;8(3):230-42
Publication Type
Article
Date
Sep-2005
Author
C. Koebnick
M. Reimann
A. Carlsohn
S. Korzen-Bohr
S. Bügel
J. Hallund
L. Rossi
F. Branca
W. Hall
C. Williams
H-J F Zunft
K. O'Doherty Jensen
Author Affiliation
German Institute of Human Nutrition Potsdam-Rehbruecke, Department of Intervention Studies, Nuthethal, Germany.
Source
Climacteric. 2005 Sep;8(3):230-42
Date
Sep-2005
Language
English
Publication Type
Article
Keywords
Age Factors
Attitude to Health
Cross-Sectional Studies
Dietary Supplements
Europe
Female
Food Habits
Health Behavior
Humans
Isoflavones - therapeutic use
Life Style
Menopause
Middle Aged
Multivariate Analysis
Phytotherapy
Questionnaires
Research Support, Non-U.S. Gov't
Vitamins - therapeutic use
Abstract
OBJECTIVE: To investigate determinants of the acceptability of isoflavone products among postmenopausal women with regard to social and lifestyle factors, dietary habits, health concerns, food beliefs, menopausal symptoms and therapies, and to elucidate preferences for specific products. METHODS: A consumer survey was conducted among postmenopausal women in four European countries (Germany, Denmark, Italy and the UK), including a total of 465 respondents. RESULTS: The declared acceptability of isoflavones was highest in Germany (80%), followed by Italy (75%), the UK (59%) and Denmark (55%; p
PubMed ID
16390755 View in PubMed
Less detail

Accuracy of actuarial procedures for assessment of sexual offender recidivism risk may vary across ethnicity.

https://arctichealth.org/en/permalink/ahliterature30268
Source
Sex Abuse. 2004 Apr;16(2):107-20
Publication Type
Article
Date
Apr-2004
Author
Niklas Långström
Author Affiliation
Centre for Violence Prevention, Karolinska Institutet, P.O. Box 23000, S-104 35 Stockholm, Sweden. niklas.langstrom@cns.ki.se
Source
Sex Abuse. 2004 Apr;16(2):107-20
Date
Apr-2004
Language
English
Publication Type
Article
Keywords
Actuarial Analysis
Adult
Africa - ethnology
Analysis of Variance
Asia - ethnology
Child
Child Abuse, Sexual - ethnology - statistics & numerical data
Cross-Sectional Studies
Europe - ethnology
Humans
Male
Middle Aged
Predictive value of tests
Questionnaires - standards
Recurrence - prevention & control
Reproducibility of Results
Research Design
Research Support, Non-U.S. Gov't
Retrospective Studies
Risk Assessment - statistics & numerical data
Risk factors
Sex Offenses - ethnology - statistics & numerical data
Sexual Behavior - ethnology - statistics & numerical data
Sweden - epidemiology
Abstract
Little is known about whether the accuracy of tools for assessment of sexual offender recidivism risk holds across ethnic minority offenders. I investigated the predictive validity across ethnicity for the RRASOR and the Static-99 actuarial risk assessment procedures in a national cohort of all adult male sex offenders released from prison in Sweden 1993-1997. Subjects ordered out of Sweden upon release from prison were excluded and remaining subjects (N = 1303) divided into three subgroups based on citizenship. Eighty-three percent of the subjects were of Nordic ethnicity, and non-Nordic citizens were either of non-Nordic European (n = 49, hereafter called European) or African Asian descent (n = 128). The two tools were equally accurate among Nordic and European sexual offenders for the prediction of any sexual and any violent nonsexual recidivism. In contrast, neither measure could differentiate African Asian sexual or violent recidivists from nonrecidivists. Compared to European offenders, AfricanAsian offenders had more often sexually victimized a nonrelative or stranger, had higher Static-99 scores, were younger, more often single, and more often homeless. The results require replication, but suggest that the promising predictive validity seen with some risk assessment tools may not generalize across offender ethnicity or migration status. More speculatively, different risk factors or causal chains might be involved in the development or persistence of offending among minority or immigrant sexual abusers.
PubMed ID
15208896 View in PubMed
Less detail

Addressing multidrug-resistant tuberculosis in penitentiary hospitals and in the general population of the former Soviet Union.

https://arctichealth.org/en/permalink/ahliterature69465
Source
Int J Tuberc Lung Dis. 1999 Jul;3(7):582-8
Publication Type
Article
Date
Jul-1999
Author
F. Portaels
L. Rigouts
I. Bastian
Author Affiliation
Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium. portaels@itg.be
Source
Int J Tuberc Lung Dis. 1999 Jul;3(7):582-8
Date
Jul-1999
Language
English
Publication Type
Article
Keywords
Communicable Disease Control - methods
Europe - epidemiology
Female
Health status
Hospitals, Special
Humans
Incidence
Male
Prisons - statistics & numerical data
Research Support, Non-U.S. Gov't
Risk factors
Tuberculosis, Multidrug-Resistant - diagnosis - epidemiology - prevention & control
USSR - epidemiology
Abstract
High rates of tuberculosis, including multidrug-resistant tuberculosis (MDR-TB), have been reported from the former Soviet Union. Our laboratory has supported operational studies in jails in Baku, Azerbaijan, and Mariinsk, Siberia. Combining the results from these two penal systems, the rates of MDR-TB among 'newly enrolled' and 'non-responding' cases were 24.6% and 92.1%, respectively. Restriction fragment length polymorphism (RFLP) studies strongly suggest transmission of MDR-TB between prisoners. In Mariinsk, the high rates of MDR-TB have been associated with failure rates of 23%-50% among smear-positive cases receiving fully-supervised standard short-course treatment. There are no coherent guidelines for TB control programmes confronted by high pre-existing levels of MDR-TB but who have only limited laboratory, clinical, pharmaceutical and financial resources. A 'DOTS plus' strategy has been advocated in which an established TB control programme is complemented by facilities to treat MDR-TB patients. However, the exact format of these programmes remains unresolved. Further research is required to describe the natural history of MDR-TB infection, to determine the failure rate of (and the additional resistance induced by) standard short-course treatment when MDR-TB is prevalent, to decide whether standardised or individualised second-line regimens can be employed, and to define the laboratory facilities required by a 'DOTS plus' programme.
PubMed ID
10423220 View in PubMed
Less detail

821 records – page 1 of 83.